Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus

Journal of Immunology

Volumn 168, Issue 1, 2002, Pages 356-364

  King, C L ^a   Malhotra, I ^a   Wamachi, A ^a   Kioko, J ^a   Mungai, P ^a   Wahab, S A ^a   Koech, D ^a   Zimmerman, P ^a   Ouma, J ^a   Kazura, J W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DNA; EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; MEMBRANE PROTEIN;

ADULT; ARTICLE; B LYMPHOCYTE; CONGENITAL INFECTION; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; FETUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALARIA; MEROZOITE; NEWBORN; NONHUMAN; PARASITE; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0036135558     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.1.356     Document Type: Article

References (68)

1. Epidemiology, malaria and pregnancy
2. Parasite adhesion and immune evasion in placental malaria
3. Newborn splenic volumes vary under different malaria endemic conditions
4. Biometric study of spleen and liver weights in Africans and Europeans-with special reference to endemic malaria
5. Clinical case definitions for malaria: Clinical malaria associated with very low parasite densities in African infants
6. High incidence of asymptomatic malara infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction
7. Lack of association between maternal antibody and protection of African infants from malaria infection
8. Plasmodium falciparum-specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternal-cord sera from east Sepik Province. Papua New Guinea
9. Some factors influencing the induction, maintenance and degree of maternally transmitted protective immunity to malaria (Plasmodium berghei)
10. Perinatal immune priming in malaria: Antigen-induced blastogenesis and adoptive transfer of resistance by splenocytes from rats born of Plasmodium berghei infected females
11. A case of congenital malaria in Malaysia with IgM malaria antibodies
12. Relationships between maternal malaria and malarial immune responses in mothers and neonates
13. Prenatal immune priming in malaria: Antigen-specific blastogenesis of cord blood lymphocytes from neonates born in a setting of holoendemic malaria
14. Malaria cellular immune responses in neonates from Cameroon
15. Relapsing malaria infection acquired in Kenya
16. Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP(19)) variants secreted from Saccharomyces cerevisiae
17. Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1
18. Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya
19. Cytokine control of parasite-specific anergy in human lymphatic filariasis: Preferential induction of a regulatory T helper type 2 lymphocyte subset
20. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge
21. B cell sensitization to helminthic infection develops in utero in humans
22. Random distribution of mixed species malaria infections in Papua New Guinea
23. Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae, and P. ovale in Kenya
24. Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates
25. Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels
26. Genetic variation and the recent worldwide expansion of Plasmodium falciparum
27. Diversity of Plasmodium falciparum populations and complexity of infections in relation to transmission intensity and host age: A study from the Usambara Mountains
28. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum
29. Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: Evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds
30. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults
31. A conserved parasite serine protease processes the Plasmodium falciparum merozoite surface protein-1
32. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria
33. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1
34. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum
35. Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: Relationships with clinical malaria and with entomological inoculation rates
36. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity
37. Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children
38. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1
39. Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro
40. Secretion of parasite-specific immunoglobulin G by purified blood B lymphocytes from immune individuals after in vitro stimulation with recombinant Plasmodium falciparum merozoite surface protein-119 antigen
41. Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax
42. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed. and/or -rechallenged Aotus vociferans monkeys
43. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial
44. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria
45. Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice
46. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants
47. Biology of malarial liver stages: Implications for vaccine design
48. Neonatal (cord blood) T cells can competently raise type 1 and 2 immune responses upon polyclonal activation
49. Measurement of T-helper cytokines secreted by cord blood mononuclear cells in response to allergens
50. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid
51. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1
52. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum
53. Immunity to erythrocytic stages of malarial parasites
54. Plasmodium yoelii yoelii 17XL MSP-1: Fine-specificity mapping of a discontinuous, disulfide-dependent epitope recognized by a protective monoclonal antibody using expression PCR (E-PCR)
55. Assessment of age-dependent immunity to malaria in transmigrants
56. Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic
57. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface prorein-1 19-kilodalton domain of Plasmodium falciparum in pregnant women and infants: Associations with febrile illness, parasitemia, and anemia
58. + malaria-specific responses from non-exposed donors
59. Plasmodium falciparum- and merozoite surface protein 1-specific antibody isotype balance in immune Senegalese adults
60. Neonatal and early life immune responses to various forms of vaccineantigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern which persists after adult boosting
61. Fetal immune response
62. Use of a recombinant baculovirus product to measure naturally-acquired human antibodies to disulphide-constrained epitopes on the P. falciparum merozoite surface protein-1 (MSP1)
63. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae
64. Induction of antibodies to the Plasmodium falciparum merozoite surface protein-1 (MSP1) by cross-priming with heterologous MSP1s
65. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains
66. Different Plasmodium falciparum recombinant MSP1(19) antigens differ in their capacities to stimulate in vitro peripheral blood T lymphocytes in individuals from various endemic areas
67. Functional conservation of the malaria vaccine antigen MSP-119 across distantly related Plasmodium species
68. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria